Advances in the classification of diffuse large B cell lymphoma(DLBCL) based on genetic aberrations and molecular expressionprofiles have led to the recognition of a new category of high grade Bcell lymphoma, including“high grade B-cell lymphoma withrearrangements of MYC and BCL2 and/or BCL6”, in the 2016revised4theditionofWorldHealth Organization (WHO)Classification of Tumors of Haematopoietic and Lymphoid Tissue
The 2016 revised World Health Organization (WHO) classification includes several provisional borderl...
In the past decade, patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL) were treated...
International audienceAims Diffuse large B-cell lymphoma (DLBCL) is the most common type of aggressi...
Diffuse large B-cell lymphomas (DLBCLs) are aggressive B-cell neoplasms with considerable clinical, ...
Our understanding of mature aggressive B cell lymphomas has evolved significantly in the last years ...
Simple Summary Diffuse large B-cell lymphoma (DLBCL) is one of the most frequent non-Hodgkin lympho...
Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) are aggressive tumors of mature B ce...
Diffuse large B-cell lymphoma (DLBCL) with MYC alteration is classified as high-grade B-cell lymphom...
Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) are aggressive tumors of mature B ce...
Using a Burkitt lymphoma-like gene expression signature, we recently defined a high-risk molecular h...
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease comprising multiple genetic subtype...
PurposeBiologic heterogeneity is a feature of diffuse large B-cell lymphoma (DLBCL), and the existen...
The 2016 World Health Organization classification defines diffuse large B-cell lymphoma (DLBCL) subt...
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours (WHO-HAEM...
Diffuse large B-cell lymphoma (DLCL) is characterized by a marked degree of morphologic and clinical...
The 2016 revised World Health Organization (WHO) classification includes several provisional borderl...
In the past decade, patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL) were treated...
International audienceAims Diffuse large B-cell lymphoma (DLBCL) is the most common type of aggressi...
Diffuse large B-cell lymphomas (DLBCLs) are aggressive B-cell neoplasms with considerable clinical, ...
Our understanding of mature aggressive B cell lymphomas has evolved significantly in the last years ...
Simple Summary Diffuse large B-cell lymphoma (DLBCL) is one of the most frequent non-Hodgkin lympho...
Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) are aggressive tumors of mature B ce...
Diffuse large B-cell lymphoma (DLBCL) with MYC alteration is classified as high-grade B-cell lymphom...
Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) are aggressive tumors of mature B ce...
Using a Burkitt lymphoma-like gene expression signature, we recently defined a high-risk molecular h...
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease comprising multiple genetic subtype...
PurposeBiologic heterogeneity is a feature of diffuse large B-cell lymphoma (DLBCL), and the existen...
The 2016 World Health Organization classification defines diffuse large B-cell lymphoma (DLBCL) subt...
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours (WHO-HAEM...
Diffuse large B-cell lymphoma (DLCL) is characterized by a marked degree of morphologic and clinical...
The 2016 revised World Health Organization (WHO) classification includes several provisional borderl...
In the past decade, patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL) were treated...
International audienceAims Diffuse large B-cell lymphoma (DLBCL) is the most common type of aggressi...